As you may have read in yesterday’s press release, we are taking cases related to the cholesterol drugs Zocor and Vytorin.
These two pharmaceuticals are statins, which means they are used to lower cholesterol. Statins can have rare but serious adverse side effects involving muscle damage. The FDA has connected the 80mg dose of Zocor and Vytorin to myopathy and rhabdomyolysis (rhabdo) – two muscle damage conditions.
Myopathy is a muscle-weakening condition that is fairly common but can be severe. Rhabdo is so serious that it always requires treatment. 22% of rhabdo victims do not survive, and 56% suffer from kidney damage.
In addition, Zocor and Vytorin are contraindicated for patients over 65, which means it is inadvisable to prescribe them to seniors. This particular contraindication is very unusual for a drug meant to lower cholesterol, as many of the patients requiring such a drug are over 65 years old.
If you or someone you care about has taken Zocor or Vytorin and now has myopathy or rhabdo, let us talk with you about your options. It doesn’t cost anything for a consultation, and hopefully it could offer you and your loved ones some relief in a difficult time.